US Department of Defense

The Ellume COVID-19 Home Test was the first rapid self-test authorized by the FDA for the detection of COVID-19 in individuals with or without symptoms.
By  Mallory Hackett 11:47 am February 2, 2021
The Biden administration has cut a deal with Australian digital diagnostics company Ellume to increase the availability of its at-home rapid response COVID-19 test kit in the U.S. The Department of Defense, with the Department of Health and Human Services, will pay $231.8 million for Ellume to deliver 8.5 million tests across the U.S. in accordance with the National Strategy for the COVID-19...
By  Aditi Pai 11:33 am September 4, 2015
Bethesda, Maryland-based BrainScope, which has developed mobile, non-invasive devices that help medical professionals assess Traumatic Brain Injury (TBI), raised $2.5 million, according to an SEC filing. This brings the company's total funding to at least $6.2 million to date. BrainScope currently offers two traumatic brain injury assessment devices. The first, Ahead 100, was cleared in November...